Tirzepatide Significantly Reduces Weight in Patients with OSA
New analysis from SURMOUNT-1 support the use of GLP-1/GIP agonist tirzepatide to reduce weight in patients with OSA and obesity/overweight.
Source: hcplive.com
Published April News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Published April. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Published April Today - Breaking & Trending Today
4 Genius Gems To Boost That Credit Score
Delinquent payments and collections can have a major negative impact on a credit score. Here's how you can avoid that trap.
Source: blackenterprise.com
Kevin Peterson, MD, MPH: Incretin Therapy's Potential
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
Source: hcplive.com
FDA Advisory Committee Meeting to Review MDMA-Assisted Therapy for PTSD
Lykos Therapeutics' new drug application for MDMA plus psychiatric intervention for adults with PTSD will be the first reviewed by an FDA committee for such a therapy.
Source: hcplive.com
Bimekizumab Shows Sustained Efficacy in Treating Axial Spondyloarthritis for 52 Weeks
Results from a study presented at the Academy of Managed Care Pharmacy 2024 annual meeting demonstrated sustained efficacy of bimekizumab compared with placebo in patients with non-radiographic and radiographic axial spondyloarthritis (axSpA) at week 52.
Source: ajmc.com